Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report.
The anemia of pregnancy in presence of beta-thalassemia intermedia usually aggravates pregnancy procedure. In the present study we investigated whether the administration of recombinant human erythropoietin (rHuEpo) recombinant human erythropoietin in combination with iron and folic acid may ameliorate blood indices as an alternative choice to blood transfusion.
Lialios
G
G
Department Obstetric and Gynecology, University of Ioannina.
Makrydimas
G
G
Tsanadis
G
G
Lolis
D
D
Bourantas
K
K
D000328:Adult; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011994:Recombinant Proteins; D017086:beta-Thalassemia / Q000188:drug therapy*
D011994:Recombinant Proteins; D004921:Erythropoietin